Tag:#Pharma cannabis

News

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025

COMBINED sales of the three most lucrative cannabis pharmaceuticals products - Epidiolex, Dronabinol and Sativex - are set to reach €1.8 billion by 2025,...

Peter - September 3, 2021

News

‘Patient Capital’ Backing LSE Debutant As It Eyes A Multi-Billion Pound Prize

LONDON Stock Exchange debutant Oxford Cannabinoid Technologies is aiming to emulate the success of GW Pharmaceuticals. Its founders Gavin Sathianathan and Neil Mahapatra were two...

Peter - May 25, 2021

Latest news

NewsMarch 17, 2023

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...

- Advertisement -

NewsMarch 16, 2023

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Press ReleasesMarch 15, 2023

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read

NewsMarch 17, 2023

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals Celadon Pharmaceuticals stock has skyrocketed by more than...

Medicinal CannabisMarch 15, 2023

Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow

TOMORROW, Germany’s Federal Joint Committee (G-BA) is expected to...

Tag:#Pharma cannabis

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

Must read

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow

Editor Picks

Huge Stride For UK Medicinal Cannabis With £12m Plan To Cultivate 300,000 Plants A Year

Amazon Enters CBD Retail Market – But Only In One Country

New ‘Cannabis Initiative’ From ‘Secretive’ UN Body May Cause Serious Harm To Global Industry

Must Read

Can CBD Be Sold As ‘Hemp Oil’ To Avoid Novel Food Rules?

Legal UK Cannabis Industry Mapped Out For First Time – And Poised For Rapid Change

Europe’s CBD U-Turn Set To Cause Widespread Harm To Businesses And Consumers

BusinessCann

About BusinessCann

Follow Us